Search Within

Dmitriy Zamarin

  1. "Gynecologic Medicine Service"
Formats
  1. Journal Article (101)
  2. Meeting Abstract (85)
  3. Editorial (7)
  4. Guidelines (3)
  5. Review (3)
  6. Book Section (2)
Groups
  1. Department of Medicine (201)
  2. GDMT, Medicine (201)
  3. Gynecologic Medicine Service (201)
  4. Gynecology Disease Management Team (201)
  5. Solid Tumor Oncology Division (201)
  6. GSK Faculty (75)

More Groups

People
  1. Carol Aghajanian (60)
  2. Britta Weigelt (50)
  3. Roisin O'Cearbhaill (42)
  4. Claire Friedman (40)
  5. Jedd Wolchok (34)
  6. Nadeem Abu-Rustum (34)

More People

Years
  1. 2024 (8)
  2. 2023 (18)
  3. 2022 (40)
  4. 2021 (16)
  5. 2020 (43)
  6. 2019 (14)

More Years

Publications
  1. Gynecologic Oncology (35)
  2. Journal of Clinical Oncology (24)
  3. Journal for ImmunoTherapy of Cancer (20)
  4. Cancer Research (13)
  5. Clinical Cancer Research (11)
  6. International Journal of Gynecological Cancer (9)

More Publications

Publishers
  1. Elsevier Inc. (37)
  2. American Association for Cancer Research (32)
  3. American Society of Clinical Oncology (29)
  4. Biomed Central Ltd (20)
  5. Nature Publishing Group (20)
  6. Lippincott Williams & Wilkins (11)

More Publishers

Results (201)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Evolution of intra-tumoral and peripheral pro-tumorigenic response during primary cytoreductive surgery for ovarian cancer
    Meeting Abstract

    Praiss, A.; Moukarzel, L.; Zhu, Y.; Derakhshan, F.; Hoang, T.; Pesci, G.; Green, H.; Hanlon, E.; Gardner, G.; Roche, K. L.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Surgical stress promotes IL-6-driven tumor progression in ovarian cancer
    Meeting Abstract

    Praiss, A.; Longhini, A. L. F.; Pesci, G.; Green, H.; Ozsoy, M.; Kahn, R.; Brodeur, M.; Bhaloo, S.; Merghoub, T.; Wolchok, J.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Oncolytic immunotherapy with recombinant Newcastle disease virus-encoding interleukin-12 in ovarian cancer mouse models
    Meeting Abstract

    Kahn, R.; Green, H.; Pesci, G.; Burman, B.; Praiss, A.; Ozsoy, M.; Brodeur, M.; Bhaloo, S. I.; Abu-Rustum, N.; Chi, D.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Evolution of peripheral and tumor immune parameters as biomarkers of differential sequencing of immune checkpoint blockade and chemoradiotherapy in locally advanced cervical cancer: An NRG Oncology/GOG Study
    Meeting Abstract

    Zamarin, D.; Deng, W.; Lankes, H.; Ghamande, S.; Holman, L.; Mathews, C.; Park, K.; Banbury, B.; Sherry, N.; Kim, H.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Transforming ovarian cancer care by targeting minimal residual disease
    Editorial

    Jazaeri, A. A.; Grisham, R.; Knisely, A.; Spranger, S.; Zamarin, D.; Hillman, R. T.; Lawson, B. C.; Burns, K. H.; Lee, S.; Westin, S. N.; more...
    Med (2023)

    Fulltext@MSK | Save
  • Assessing the genomic landscape of cervical cancers: Clinical opportunities and therapeutic targets
    Journal Article

    Friedman, C. F.; Ravichandran, V.; Miller, K.; Vanderbilt, C.; Zhou, Q.; Iasonos, A.; Vivek, M.; Mishra, P.; Leitao, M. M. Jr; Broach, V.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Tumor lenvatinib addiction and withdrawal rebound response in patients with advanced endometrial cancer
    Journal Article

    Lam, C.; Sarasohn, D.; Weigelt, B.; Zamarin, D.
    Gynecologic Oncology Reports (2023)

    Fulltext@MSK | Save
  • CRI-CCTG-0003/IND.240: An immunotherapy platform study in platinum-resistant high grade serous ovarian cancer (IPROC)
    Meeting Abstract

    Mackay, H.; Tinker, A.; Nelson, B.; Zamarin, D.; Odunsi, K.; Lheureux, S.; Ellard, S.; Smrke, A.; Gaudreau, P. O.; Faulkner, T.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Germline variants in non- BRCA1/2 homologous recombination-related genes and ovarian cancer: Analysis of tumor phenotype and survival
    Meeting Abstract

    Kahn, R. M.; Selenica, P.; Boerner, T.; Xiao, Y.; Sia, T.; Sheehan, M.; Zhou, Q.; Iasonos, A.; Grisham, R. N.; O'Cearbhaill, R. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG Oncology/Gynecologic Oncology Group study 0283
    Journal Article

    O'Cearbhaill, R. E.; Miller, A.; Soslow, R. A.; Lankes, H. A.; DeLair, D.; Segura, S.; Chavan, S.; Zamarin, D.; DeBernardo, R.; Moore, K.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save